In-vitro Anti-inflammatory activity of Siddha Drug “ Dhrakshathy Mathirai” by Protein (Albumin) Denaturation Assay

R.MEERA1 , A.KINGSLY2

1 P.G. Scholar, P.G. Gunapadam Department, Govt. Siddha Medical College, Palayamkottai, Tirunelveli, Tamilnadu , India.

2 Reader and H.O.D, P.G.Gunapadam Department, Govt. Siddha Medical College, Palayamkottai, Tirunelveli, Tamilnadu, India.

ABSTRACT:

Siddha system is one of the ancient system of medicine. This system cure many diseases purely on herbs. In this present study anti-inflammatory potential of the Siddha formulation “Dhrakshathy Mathirai” (DM) was investigated. Based on the resulted the extract of the drug showed the highest anti-inflammatory activity. The increments in absorbance of test samples with respect to control indicated stabilization of protein i.e., inhibition of heat induced protein (albumin) denaturation by DM and reference drug diclofenac sodium.

Keywords: Siddha, Dhrakshathy mathirai , anti-inflammatory activity, diclofenac sodium.

INTRODUCTION:

Asthma is a chronic reversible inflammatory destructive disease of the airways characterized by recurrent paroxysmal attacks of dyspnoea chiefly expiratory in nature accompanied by wheeze which may subside spontaneously or with treatment [1].Inflammation is a response of the immune system to an injury which is beneficial to the host under normal circumstances. However, an aberrant immune response to non-pathogenic stimuli in the asthmatic airway leads to a chronic inflammatory response relevant to the pathogenesis of the disease. Episodes of acute inflammatory reactions are often accompanied by an underlying chronic inflammation even in the absence of continuous allergen exposure. The complex interplay between the multi-cellular inflammatory infiltrate and parenchymal lung tissue cells is characterized by a broad network of self amplifying bioactive mediators, including cytokines, antibodies and growth factors. Inflammatory leukocyte recruitment is directed by small inflammatory soluble molecules known as chemokines. Inappropriate immune activation is thought to be, in part, is responsible for the chronicity of allergic asthma, however there is now increasing evidence that dysregulation of endogenous immune regulating processes are, in part, are responsible for the development of this disease [2].

Drugs which are used presently for the management of pain and inflammatory conditions may produce adverse effects. On the other hand, polyherbal medicines which are safe, effective, time-tested and devoid of drastic side-effects are the need of the hour. Siddha system of medicine has many herbal formulations indicated for the treatment of inflammations.

“Dhrakshathy Mathirai” mentioned in Siddha book Anuboga Vaithiya Navaneetham-Part VIII contains polyherbal drugs is indicated for bronchial asthma.

MATERIALS AND METHODS:

The test drug DM was prepared as per the Standard Operative Procedure (SOP) based on the Siddha literature, Anuboga Vaithiya Naveetham. The ingredients of the test drugs includes.

TAMIL NAME

BOTANICAL NAME

DHRAKSHAI PAZHAM

Vitis vinifera,Linn.

CHUKKU

Zingiber officinale,Roscoe.

CHITTRARATHAI

Alpinia officinarum,Hance.

THESAVARAM

Piper longum,Linn.

SATHIKKAI

Myristica fragrans,Gronov.

SATHIPATHIRI

Myristica fragrans,Gronov.

LAVANGAM

Syzygium aromaticum,Linn.

VALMILAGU

Piper cubeba,Linn.

LAVANGA PATTAI

Cinnamomum verum,J.Presl.

ATHIMATHURAM

Glycyrrhiza glabra,Linn.

ELAM

Elettaria cardamomum,Linn.

KUNGUMAPOO

Crocus sativus,Linn.

KARKANDU

Borassus flabellifer,Linn.

In-vitro Anti-Inflammatory Activity by Protein (Albumin) denaturation Assay

Sample Name : Dharkshathy Mathirai

Sample ID : DM

Sample Analysis

State

Semi Solid

Appearance

Dark Brownish

Solubility Assay

S.No

Solvent Used

Solubility

1.

Chloroform

Insoluble

2.

Ethanol

Soluble

3.

Water

Soluble

4.

Ethyl acetate

Insoluble

5.

DMSO

Soluble

Stock: 10mg/ml

Albumin Denaturation Assay Procedure

In-vitro anti-inflammatory activity DM was studied using albumin denaturation technique. The reaction mixture consisted of bovine serum albumin (5% aqueous solution) and test sample DM at varying concentration ranges from 100 to 500 µg/ml and standard Diclofenac sodium at the concentration of100 µg /ml of final volume. pH was adjusted by using a small amount of 1N Hydrochloric acid. The samples were incubated at 37°C for 20 min and then heated at 57°C for 3 min. After cooling the sample, 2.5 ml of phosphate buffer solution was added into each test tube. Turbidity developed was measured spectrophotometrically at 660 nm, for control distilled water was used instead of test sample while product control tests lacked bovine serum albumin. The experiment was performed in triplicate.

The Percentage protection from denaturation is calculated by using the formulae

Statistical analysis

Results are expressed as Mean ± SD. The difference between experimental groups was compared by One-Way Analysis Of Variance (ANOVA) followed by Dunnet Multiple comparison test.

Preparation of Test and control

Absorbance of reaction mixture – Test Sample

Absorbance of reaction mixture – Control and Standard

Absorbance Range of test and standard at Trial 1

Absorbance Range of test and standard at Trial 2

Absorbance Range of test and standard at Trial 3

FINAL RESULT

Concentration in µg/ml

Absorbance

Control

1.016 ± 0.001

DM 100

0.84 ± 0.030

DM 200

0.73 ± 0.025

DM 300

0.62 ± 0.020

DM 400

0.56 ± 0.017

DM 500

0.49 ± 0.065

Diclofenac sodium (100 µg)

0.05 ± 0.043


Each value represents the mean ± SD. N=3

Concentration in µg/ml

Percentage Inhibition of Protein Denaturation

DM 100

18.21 ± 2.751

DM 200

29.03 ± 2.636

DM 300

40.19 ± 2.198

DM 400

46.43 ± 1.534

DM 500

53.33 ± 6.234

Diclofenac sodium (100 µg)

96.65 ± 4.246

Each value represents the mean ± SD. N=3

Result and Discussion:

The result obtained from the present clearly indicates that the test drug DM was effective in inhibiting heat induced albumin denaturation. Maximum percentage inhibition of about 53.33 % was observed at 500 μg/ml when compare to that of the Diclofenac sodium, a standard anti-inflammatory agent with the maximum inhibition 96.65 % at the concentration of 100 μg/ml. From the result of the study it was concluded that the test drug DM possess promising anti-inflammatory property in protein denaturation assay.

Reference

1. Prof.P.C.Das, MD(CAL),FICA(USA),FCCP(USA), Dr.P.K.Das, MD-Text book of Medicine-6th ed; Current Book International,Kolkata,2016.pp114.

2. Jenna R.Murdoch and Clare M.Lloyd. Chronic inflammation and Asthma. Mutat Res. 2010 Aug 7; 690(1-2):24-39.

3. G.Leelaprakash, S.Mohan Dass. In-vitro anti-inflammatory activity of methanol extract of enicostemma axillare. Int. J. Drug Dev. & Res., 2011, 3 (3): 189-196.

4. M. V. Anoop, A. R. Bindu . In-vitro Anti-inflammatory Activity Studies on Syzygium zeylanicum (L.) DC Leaves. International Journal of Pharma Research & Review, August 2015; 4(8):18-2

5. Vaithyarathnam K.S. Murugesamuthaliyar, Gunapadam- mooligai, Directorate of Indian Medicine and Homeopathy, Chennai-106, 1936.

6. Dr.S.Somasundaram,M.Sc.,M.Phil.,E.S.M.P.,Ph.D., Maruthuva Thavara Iyal, Vol-I, 1997,Elangovan pathipagam,Tirunelveli-2.

7. Hakeem.P.M.Abdulla Saheeb, Anuboga Vaithya Naveetham part- VIII, 2 nd ed; april 2002,Thamarai noolagam,7,N.G.O.colony, vadapalani,Chennai-26.